Temple Rock Holdings Inc.

CYNAPSUS THERAPEUTICS ANNOUNCES TRANSFER OF COMMON SHARES
TORONTO, ONTARIO--(Marketwire - Dec. 17, 2010) -Cynapsus Therapeutics Inc. ("Cynapsus" or the "Corporation") (formerly Cannasat Therapeutics Inc.) (TSX VENTURE:CTH) announced today that, effective December 16, 2010, pursuant to the terms of a security purchase agreement dated as of November 15, 2010 among Lorne Gertner and David Hill (collectively, the "Purchasers") and the Vendor, an aggregate of 7,780,878 Common shares in the capital of the Corporation (the "Shares") have been transferred by the Vendor to the Purchasers. MORE>>